BIOTRONIK Conduction System Pacing With the Solia Lead
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 194 participants.
Also called NCT05251363
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 194 participants
- Sponsor
- Registry
-
NCT05251363
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- United States
- Registry status
- Completed
Technical summary
Registry record NCT05251363. Allocation not applicable; no masking; primary purpose treatment. Start 2022-12-12 (actual); primary completion 2024-01-09 (actual). Results posted on 2025-03-18.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- BIOTRONIK Conduction System Pacing With the Solia Lead
- Acronym
- BIO-CONDUCT
- Condition
- Bradycardia
- Condition
- Atrioventricular Block
- Condition
- Left Bundle-Branch Block
- Condition
- Cardiomyopathies
- Intervention (Device)
- Solia S lead
- Lead sponsor
- Biotronik, Inc.
Record details
- Record id
cardio:ct-nct05251363- Content hash
e591a6eb7814a41c5c45cd0f273528abffb840b4c36a2d05eece6b5540bdaf84